patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
Obesity
Preclinicalupdated 2mo agoby Metallomix Inc
Preclinicalcommunity read0 votes
indications
indications
Obesity
all catalysts(0)
nothing on the calendar yet
News(7)
- Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs“We're basically not using our body as directed,” says "Drug Story" host Thomas Goetz.stat · 2mo ago
- STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.stat · 2mo ago
- Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
- STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and morePresident Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White Housestat · 2mo ago
comments(0)
5-min edit window · permanent after that